FOR IMMEDIATE RELEASE

Contact:

Jon Muskrat

860.321.2264|jmuskrat@BreakthroughT1D.org

Breakthrough T1D Greater CT/Western MA Announces Christopher O’Connor as 2024 Star of Hope Award Recipient

 

(Farmington, Conn., January 10, 2023) – Breakthrough T1D Greater CT/Western MA is pleased to announce that Christopher O’Connor, Chief Executive Officer and President of Yale New Haven Health System, will be honored with the Star of Hope award at the 2024 Promise Ball.  Mr. O’Connor was chosen for his passionate commitment to Breakthrough T1D’s mission of accelerating life-changing breakthroughs to cure, prevent and treat type 1 diabetes (T1D) and its complications.

 

“I am honored to receive the Star of Hope Award at the 2024 Breakthrough T1D Promise Ball,” said O’Connor. “I am proud to support the incredible work that Breakthrough T1D does, both for my family and the many other families living with T1D.  I am deeply moved by the strength of the T1D community as well as those who are directly impacted by the funds raised through this event. We are looking forward to an amazing evening at Mohegan Sun.”

 

The 2024 Breakthrough T1D Promise Ball will be held on Saturday, April 27^th at Mohegan Sun.  For more information about the 2024 Promise Ball, please visit https://bit.ly/PromiseBall2024

 

About Type 1 Diabetes
Type 1 diabetes (T1D) is an autoimmune disease that impacts millions of people around the world. The disease occurs when the body’s immune system attacks and destroys the beta cells in the pancreas that produce insulin, a hormone essential to turning food into energy. Without insulin, glucose from food stays in the blood, where it can cause serious damage to all of the body’s organ systems. It requires constant carbohydrate counting, blood-glucose testing, and lifelong dependence on injected insulin. With T1D there are no days off, and there is no cure.

About Breakthrough T1D
Breakthrough T1D is the leading global organization funding type 1 diabetes (T1D) research. Our mission is to accelerate life-changing breakthroughs to cure, prevent and treat T1D and its complications. To accomplish this, Breakthrough T1D has invested nearly $2 billion since our inception. We are an organization built on a grassroots model of people connecting in their local communities, collaborating regionally for efficiency and broader fundraising impact, and uniting on a national stage to pool resources, passion, and energy. We collaborate with academic institutions, policymakers, and corporate and industry partners to develop and deliver a pipeline of innovative therapies to people living with T1D. Our staff and volunteers in Breakthrough T1D Greater CT/Western MA, and in more than 100 locations throughout the United States and our six international affiliates are dedicated to advocacy, community engagement and our vision of a world without T1D. For more information, please visit jdrf.org.